Why is "Zidovudine" trending?

Search Interest Perspective

• Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV - NEJM
• The Complete List of Approved HIV Drugs - Verywell Health
• In vitro synergy screens of FDA-approved drugs reveal novel zidovudine- and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae | Scientific Reports - Nature
• Zidovudine reduces maternal-infant HIV transmission [Classics Series] - 2 Minute Medicine
• A fossil record of zidovudine resistance in transmitted isolates of HIV-1 - PNAS
• Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV - NEJM
• Acute liver failure enhances oral plasma exposure of zidovudine in rats by downregulation of hepatic UGT2B7 and intestinal P-gp - Nature
• Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment - NEJM
• Primary Infection with Zidovudine-Resistant Human Immunodeficiency Virus Type 1 - NEJM
• Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy - NEJM
• Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa - NEJM
• A Trial of Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1 - NEJM
• Abbreviated Regimens of Zidovudine Prophylaxis and Perinatal Transmission of the Human Immunodeficiency Virus - NEJM
• A Controlled Trial of Early versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus Infection - NEJM
• Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter - NEJM
• Evaluation of the Quality of Life Associated with Zidovudine Treatment in Asymptomatic Human Immunodeficiency Virus Infection - NEJM
• A Controlled Trial Comparing Continued Zidovudine with Didanosine in Human Immunodeficiency Virus Infection - NEJM
• A Survey of Zidovudine Use in Pregnant Women with Human Immunodeficiency Virus Infection - NEJM
• Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant - NEJM
• Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway | Cell Death & Disease - Nature
• The Story Behind the First AIDS Drug, Approved 30 Years Ago - Time Magazine
• Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals - The Lancet
• Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine - NEJM
• Zidovudine and Red-Cell Distribution Width - NEJM
• A Comparison of Immediate with Deferred Zidovudine Therapy for Asymptomatic HIV-Infected Adults with CD4 Cell Counts of 500 or More per Cubic Millimeter - NEJM
• A Pilot Study of Low-Dose Zidovudine in Human Immunodeficiency Virus Infection - NEJM
• Treatment of Adult T-Cell Leukemia–Lymphoma with a Combination of Interferon Alfa and Zidovudine - NEJM
• Recombinant Human Erythropoietin for Patients with AIDS Treated with Zidovudine - NEJM
• Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection | NEJM - NEJM
• Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons - PNAS
• Zidovudine in Persons with Asymptomatic HIV Infection and CD4+ Cell Counts Greater than 400 per Cubic Millimeter - NEJM
• Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV Infection - NEJM
• A Comparative Trial of Didanosine or Zalcitabine after Treatment with Zidovudine in Patients with Human Immunodeficiency Virus Infection - NEJM
• Zidovudine Alone or in Combination with Didanosine or Zalcitabine in HIV-Infected Patients with the Acquired Immunodeficiency Syndrome or Fewer Than 200 CD4 Cells per Cubic Millimeter - NEJM
• A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection - NEJM
• Combination Treatment with Zidovudine, Didanosine, and Nevirapine in Infants with Human Immunodeficiency Virus Type 1 Infection - NEJM
• Second-line TAF-based ART improves viral suppression in pediatric HIV - 2 Minute Medicine
• Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial - The Lancet
• Short-term toxicity assessment of combined use of zidovudine, lamivudine and lopinavir/ritonavir in vitro and in vivo - onlinelibrary.wiley.com
• A Multicenter Trial of Oral Zidovudine in Children with Advanced Human Immunodeficiency Virus Disease - NEJM
• Zidovudine and the Natural History of the Acquired Immunodeficiency Syndrome - NEJM
• Enhanced Antiviral Ability by a Combination of Zidovudine and Short Hairpin RNA Targeting Avian Leukosis Virus - Frontiers
• Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected Children - NEJM
• Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults - NEJM
• Failure of Zidovudine Prophylaxis after Accidental Exposure to HIV-1 - NEJM
• A Randomized Controlled Trial of a Reduced Daily Dose of Zidovudine in Patients with the Acquired Immunodeficiency Syndrome - NEJM
• Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial - The Lancet
• Cardiomyopathy with Mitochondrial Damage Associated with Nucleoside Reverse-Transcriptase Inhibitors - NEJM
• Recycling tenofovir better than switch to second-line zidovudine - Aidsmap
• Risk Factors for Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Women Treated with Zidovudine - NEJM
• Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention - NEJM
• Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial - The Lancet
• New drug regimens cut HIV spread from mother to infant, NIH study shows - UCLA Health
• Virtual Exhibits of FDA History - fda.gov
• Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial - The Lancet
• Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues - The Lancet
• Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma - Nature
• Neuropsychological Outcome of Zidovudine (AZT) Treatment of Patients with AIDS and AIDS-Related Complex - NEJM
• HIV-associated dementia - Neurology® Journals
• Transmission from One Child to Another of Human Immunodeficiency Virus Type 1 with a Zidovudine-Resistance Mutation - NEJM
• 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial - The Lancet
• A Controlled Trial of Intravenous Immune Globulin for the Prevention of Serious Bacterial Infections in Children Receiving Zidovudine for Advanced Human Immunodeficiency Virus Infection - NEJM
• Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection - NEJM
• Toxicological evaluation of zidovudine and novel chalcogen derivatives in Drosophila melanogaster - onlinelibrary.wiley.com
• Intrapartum Exposure to Nevirapine and Subsequent Maternal Responses to Nevirapine-Based Antiretroviral Therapy - NEJM
• Reversed phase HPLC determination of zidovudine in rat plasma and its pharmacokinetics after a single intranasal dose administration - SciELO Chile
• Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial - The Lancet
• Infant prophylaxis during breastfeeding reduces risk of HIV infection by 71% - Aidsmap
• Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection - NEJM
• Dolutegravir Confirmed as Effective Second-Line HIV Therapy; Recycling Tenofovir Noninferior to Zidovudine - Medscape
• Postexposure Prophylaxis for HIV Infection - NEJM
• A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter - NEJM
• Further evidence that recycling tenofovir in second-line treatment is effective - Aidsmap
• A Short-Term Clinical Evaluation of L-697,661, a Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase - NEJM
• Alfredo Ceibal | Zidovudine AZT (1994) - mutualart.com
• Zidovudine Price Trend, Chart, Index and Forecast - IMARC Group
• Update: Perinatally Acquired HIV/AIDS -- United States, 1997 - Centers for Disease Control and Prevention | CDC (.gov)
• Unlocking innovative hydrogel treatments - European Pharmaceutical Review
• Leber's hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virus - Nature
• Neurotoxic effects of AZT on developing and adult neurogenesis - Frontiers
• Human adenovirus DNA polymerase is evolutionarily and functionally associated with human telomerase reverse transcriptase based on in silico molecular characterization that implicate abacavir and zidovudine - Frontiers
• Melanonychia in Patients Infected with Human Immunodeficiency Virus Original Communication - SCIRP Open Access
• The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter - NEJM
• FDA Advisory No.2024-1659 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Lamivudine/Zidovudine 30 mg/60 mg Dispersible Tablets” - fda.gov.ph
• Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients - NEJM
• Drug combo much better than AZT alone at preventing mother-to-infant HIV transmission - UCLA Health
• Claims that people were being killed by zidovudine (AZT) instead of AIDS are unsubstantiated - Science Feedback
• Treat herpes, treat HIV? - Nature
• A Slightly Less Painful Way to Learn the Three-Letter Abbreviations for HIV Meds - blogs.nejm.org
• Once-Daily Administration of 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related Complex — Results of a Phase I Trial - NEJM
• The Best Antiretroviral Therapy for Pregnant Women? The Controversy Continues - blogs.nejm.org
• How Antiretrovirals Transformed the HIV Epidemic: A Timeline - poz.com
• Postexposure Prophylaxis Against Human Immunodeficiency Virus - American Academy of Family Physicians | AAFP
• protease inhibitor - Britannica
• Mitochondrial DNA Depletion, Oxidative Stress, and Mutation: Mechanisms 0f Dysfunction from Nucleoside Reverse Transcriptase Inhibitors | Laboratory Investigation - Nature
• Combination ART: are two drugs as good as three? - The Lancet
• Impact of Low-Level-Viremia on HIV-1 Drug-Resistance Evolution among Antiretroviral Treated-Patients - PLOS
• Lipodystrophy Linked to Older HIV Meds Appears Irreversible - poz.com
• Mother-to-fetus transfer of antiviral drugs and the involvement of transporters at the placental barrier - onlinelibrary.wiley.com
• Post misrepresents dangers of first FDA-approved HIV treatment | Fact check - USA Today